MEG3 and chronic myelogenous leukemia, BCR-ABL1 positive: In one experiment, after checking the MEG3 expression levels in both K562 and peripheral blood cells from CML patients, a significant decrease was observed in the expression of this lncRNA in drug-resistant cells [25].